ChromaDex (CDXC) Tops Q4 EPS by 7c

ChromaDex (NASDAQ: CDXC) reported Q4 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $26.78 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• TechCreate Group faces NYSE American delisting proceedings
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters